# Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector

> **NCT00738205** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 834 (actual)

## Conditions studied

- Growth Hormone Deficiency
- Turner Syndrome
- Chronic Renal Failure
- Small for Gestational Age

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00738205
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-06
- **Target enrollment:** 834 (ACTUAL)
- **Last updated:** 2014-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738205, "Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00738205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*